Development and validation of novel models for cerebral small vessel disease and vascular cognitive impairment
脑小血管疾病和血管性认知障碍新模型的开发和验证
基本信息
- 批准号:10684902
- 负责人:
- 金额:$ 78.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-18 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAddressAgeAge MonthsAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAnimal ModelAscorbic AcidAssociation LearningBehaviorBehavioralBiological AssayBiological MarkersBlood VesselsCADASILCalciumCell Surface ReceptorsCerebral small vessel diseaseCerebrumCharacteristicsClinicalCognitiveCognitive deficitsCountryDataDedicationsDementiaDevelopmentDiseaseDisease PathwayElectrophysiology (science)ElementsEnsureEtiologyEvaluationExperimental ModelsFemaleFunctional disorderGenesGeneticGenetic ModelsGoalsHumanImageImpaired cognitionInterventionKnowledgeLearningLesionMagnetic Resonance ImagingMediatingMemoryMeta-AnalysisMicroRNAsMicrocirculationMicrovascular DysfunctionModelingMolecularMusMutant Strains MiceMutationMyographyOutcomePathogenesisPathologyPathway interactionsPhasePhysiologicalPopulationPost-Transcriptional RegulationPre-Clinical ModelPreclinical TestingPrevention strategyProcessRadiology SpecialtyResearchStrokeSubgroupSyndromeTherapeutic InterventionValidationVascular Cognitive ImpairmentVascular Diseasesage relatedagedarterial tortuositybehavior testbrain circulationcerebral microbleedscerebrovascular pathologycognitive changecognitive functioncohortcomparativedesigneffective interventiongenetic resourcegenome wide association studygenome-wide analysishuman diseaseimaging modalityimaging studyimprovedinnovationinsightmalemouse modelneuropathologynovelpatch clamppressurepreventprospective testreceptor bindingvascular cognitive impairment and dementiawhite matter
项目摘要
PROJECT SUMMARY
Vascular cognitive impairment and dementia (VCID) is any level of cognitive alteration that is attributable to
cerebrovascular pathologies. VCID is second only to Alzheimer's disease as a cause of dementia and
accounts for ~15-30% of all dementia cases. Cerebral small vessel diseases (cSVDs) are group of pathologies
afflicting the microcirculation of the brain that collectively account for up to 20% of all strokes and is the most
common pathology underlying VCID. The impact of cSVD and VCID is expected to increase rapidly as the
population of the US and other countries ages. Importantly, the pathogeneses of cSVDs are incompletely
understood which represents a major barrier in developing strategies for prevention and treatment. Research
described in this proposal will develop and validate five novel mouse models of cSVD based on genes and
mutations that are demonstrated to contribute to human disease. We have assembled an interdisciplinary team
of experts that will integrate unique genetic resources, vascular pressure myography, patch-clamp
electrophysiology, calcium imaging, specialized magnetic resonance imaging modalities and learning and
memory behavior assays to develop and characterize multiple novel genetic models of cSVD using genes that
contribute to disease in humans. Our long-term objective is to develop and employ genetic models that
faithfully recapitulate important hallmarks of human cSVD and VCID.
项目摘要
血管性认知障碍和痴呆(VCID)是可归因于以下因素的任何水平的认知改变:
脑血管病VCID是仅次于阿尔茨海默病的第二大痴呆症病因,
占所有痴呆病例的15-30%。脑小血管疾病是一组病理学
影响大脑的微循环,这些微循环总共占所有中风的20%,
VCID背后的共同病理cSVD和VCID的影响预计将迅速增加,
美国和其他国家的人口老龄化。重要的是,cSVD的发病机制是不完全的,
这是制定预防和治疗战略的一个主要障碍。研究
该提案中描述的将开发和验证五种基于基因的cSVD新型小鼠模型,
这些突变被证明会导致人类疾病。我们组建了一个跨学科的团队
的专家,将整合独特的遗传资源,血管压力肌电图,膜片钳
电生理学,钙成像,专门的磁共振成像模式和学习,
记忆行为测定,以开发和表征cSVD的多种新的遗传模型,
会导致人类疾病我们的长期目标是开发和使用遗传模型,
忠实地概括了人cSVD和VCID的重要特征。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Myriam Marianne Chaumeil其他文献
Myriam Marianne Chaumeil的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Myriam Marianne Chaumeil', 18)}}的其他基金
Theranostic Metabolic Imaging of Oxidative Stress in Multiple Sclerosis.
多发性硬化症氧化应激的治疗诊断代谢成像。
- 批准号:
10666890 - 财政年份:2023
- 资助金额:
$ 78.37万 - 项目类别:
Imaging cerebral metabolic impairment in AD using Deuterium MRI
使用氘 MRI 对 AD 中的脑代谢损伤进行成像
- 批准号:
10608908 - 财政年份:2023
- 资助金额:
$ 78.37万 - 项目类别:
Imaging innate and adaptive immune response in MS using using [18F]F-AraG PET and hyperpolarized 13C MRSI
使用 [18F]F-AraG PET 和超极化 13C MRSI 对 MS 中的先天性和适应性免疫反应进行成像
- 批准号:
10040874 - 财政年份:2020
- 资助金额:
$ 78.37万 - 项目类别:
Development and validation of novel models for cerebral small vessel disease and vascular cognitive impairment
脑小血管疾病和血管性认知障碍新模型的开发和验证
- 批准号:
10471562 - 财政年份:2019
- 资助金额:
$ 78.37万 - 项目类别:
Application of Hyperpolarized 13C Magnetic Resonance Imaging to Detect Target Inhibition of NF-kB Activation and Response in Primary CNS Lymphoma
应用超极化13C磁共振成像检测原发性中枢神经系统淋巴瘤中NF-kB激活和反应的靶点抑制
- 批准号:
10437739 - 财政年份:2019
- 资助金额:
$ 78.37万 - 项目类别:
Application of Hyperpolarized 13C Magnetic Resonance Imaging to Detect Target Inhibition of NF-kB Activation and Response in Primary CNS Lymphoma
应用超极化13C磁共振成像检测原发性中枢神经系统淋巴瘤中NF-kB激活和反应的靶点抑制
- 批准号:
10177970 - 财政年份:2019
- 资助金额:
$ 78.37万 - 项目类别:
Application of Hyperpolarized 13C Magnetic Resonance Imaging to Detect Target Inhibition of NF-kB Activation and Response in Primary CNS Lymphoma
应用超极化13C磁共振成像检测原发性中枢神经系统淋巴瘤中NF-kB激活和反应的靶点抑制
- 批准号:
10651730 - 财政年份:2019
- 资助金额:
$ 78.37万 - 项目类别:
Development and validation of novel models for cerebral small vessel disease and vascular cognitive impairment
脑小血管疾病和血管性认知障碍新模型的开发和验证
- 批准号:
9894276 - 财政年份:2019
- 资助金额:
$ 78.37万 - 项目类别:
Understand and probing disrupted glucose metabolism in Alzheimer's disease
了解并探索阿尔茨海默病中葡萄糖代谢紊乱
- 批准号:
9802793 - 财政年份:2019
- 资助金额:
$ 78.37万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 78.37万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 78.37万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 78.37万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 78.37万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 78.37万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 78.37万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 78.37万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 78.37万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 78.37万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 78.37万 - 项目类别:
Research Grant